
GLP-1 drugs enter psychiatry, curbing antipsychotic weight gain while raising new questions about addiction, mood, eating disorders, and culture.

Dr Ali is a psychiatry resident year 1 at BronxCare Health System in New York City, with interests spanning towards a research field in psychiatry.

GLP-1 drugs enter psychiatry, curbing antipsychotic weight gain while raising new questions about addiction, mood, eating disorders, and culture.